BRIEF published on 01/21/2025 at 07:03, 1 year 9 months ago DocMorris annonce une croissance de 6,7 % en 2024 avec une forte augmentation des revenus des médicaments sur ordonnance Résultats Financiers 2024 Croissance De DocMorris Augmentation Des Revenus Des Médicaments Sur Ordonnance Performances De La TéléClinique Tendances Du Marché Allemand
PRESS RELEASE published on 01/21/2025 at 06:58, 1 year 9 months ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris grows 6.7% in 2024 with increased Rx sales, OTC revenues and TeleClinic profits. Achieved revenue target and positive cash position. Outlook confirmed for 2024 Revenue Growth DocMorris Rx Sales TeleClinic OTC Revenues
BRIEF published on 10/15/2024 at 07:03, 2 years 1 month ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
BRIEF published on 10/15/2024 at 07:03, 2 years 1 month ago DocMorris accélère la croissance des médicaments sur ordonnance Croissance Des Revenus Télésanté DocMorris AG Médicaments Sur Ordonnance Fermeture Logistique
PRESS RELEASE published on 10/15/2024 at 06:58, 2 years 1 month ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
BRIEF published on 08/20/2024 at 07:03, 2 years 3 months ago DocMorris Enhances Prescription Business and Boosts New Rx Customer Investment 2024 Outlook E-prescriptions DocMorris Prescription Business TeleClinic
BRIEF published on 08/20/2024 at 07:03, 2 years 3 months ago DocMorris améliore son activité de prescription et stimule les investissements de ses nouveaux clients en matière de prescription Perspectives 2024 Ordonnances Électroniques Doc Morris Entreprise De Prescription TéléClinique
PRESS RELEASE published on 08/20/2024 at 06:58, 2 years 3 months ago DocMorris grows in the prescription business and invests incrementally in new Rx customers DocMorris reports growth in prescription business and increased investments in new Rx customers. Break-even reached, outlook for 2024 adjusted due to e-prescription transition Financial Results E-prescriptions New Customers DocMorris Prescription Business
BRIEF published on 07/11/2024 at 07:03, 2 years 4 months ago DocMorris Reports Significant eRx Growth in Q2 2024 Revenue Increase Market Expansion DocMorris ERx Growth
BRIEF published on 07/11/2024 at 07:03, 2 years 4 months ago DocMorris annonce une croissance significative d'eRx au deuxième trimestre 2024 L'expansion Du Marché Augmentation Des Revenus DocMorris Croissance ERx
Published on 11/20/2026 at 15:00, 11 hours 27 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 11 hours 37 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 12 hours 27 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 12 hours 57 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 12 hours 57 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 2 hours 42 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 3 hours 47 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 4 hours 50 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 5 hours 37 minutes ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 7 hours 52 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 7 hours 52 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 8 hours 52 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 8 hours 52 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 7 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR